Letters
National HPV vaccination
Authors’ reply to Gupta
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f3734 (Published 11 June 2013) Cite this as: BMJ 2013;346:f3734- Basil Donovan, professor1,
- Hammad Ali, lecturer1
- 1Kirby Institute, University of New South Wales, Sydney NSW 2052, Australia
- bdonovan{at}kirby.unsw.edu.au
Gupta asks why the national human papillomavirus (HPV) vaccination programme in Australia doesn’t cover women undergoing treatment for high grade cervical disease.1 2
The quadrivalent HPV vaccine was not designed to act as a therapeutic vaccine and theoretically provides no benefit against an existing HPV infection—just as the flu vaccine doesn’t benefit people with flu. Interestingly, a retrospective analysis of data from two randomised placebo controlled trials showed reduced recurrence of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.